Abstract
Previous studies investigating the role of circulating microRNAs in acute coronary syndrome (ACS) were based on small patient numbers, performed no comparison with established markers of cardiac injury and did not have appropriate controls. We determined the potential diagnostic value of circulating microRNAs as novel early biomarkers in 332 suspected ACS patients on presentation to the emergency department (ED) in a prospective single-centre study including cardiac miRNAs (miR-1, -208a and -499), miR-21 and miR-146a. Levels of all miRs studied were significantly increased in 106 patients diagnosed with ACS, even in patients with initially negative high-sensitive (hs) troponin or symptom onset
Original language | English |
---|---|
Pages (from-to) | 1176-1185 |
Number of pages | 10 |
Journal | Embo Molecular Medicine |
Volume | 4 |
Issue number | 11 |
DOIs | |
Publication status | Published - Nov 2012 |
Keywords
- acute coronary syndrome
- circulating microRNA
- miR-1
- miR-21
- miR-499
- ACUTE MYOCARDIAL-INFARCTION
- CARDIOVASCULAR-DISEASE
- PLASMA MICRORNA
- HEART-FAILURE
- BIOMARKERS
- SERUM
- TROPONIN
- REVEALS
- MARKERS
- CANCER